Top Markets
#1 Black Phoenix Black Phoenix +355.18%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +55.04%
#4 Akedo Akedo +53.98%
#5 Acurast Acurast +32.15%
#6 BasedHype BasedHype +28.07%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +18.15%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.84%
#10 HOME HOME +14.70%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rank in Stocks #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Share Price
$0.02765
Last synced: 2024-12-23
Market Cap
$69.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Histogen Inc. (HSTO)

Category

Healthcare
Number of shares outstanding for Histogen Inc. (HSTO)
Number of shares outstanding as of September 2023: 4.27M
According to Histogen Inc. latest financial reports and stock price the company's current number of shares outstanding is 4.27M. At the end of December 2021 the company had 1.92M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Histogen Inc. (HSTO) from 2011 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 4.27M 33.04%
2022 3.21M 67.41%
2021 1.92M 325.35%
2020 450.92K -23.66%
2019 590.69K 289.00%
2018 151.85K 6.24%
2017 142.93K 26.21%
2016 113.25K -99.39%
2015 18.62M 20.28%
2014 15.48M 110.37%
2013 7.36M 15,800.25%
2012 46.28K 0.00%
2011 46.28K 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,843.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,355.65%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE